SCHEMBL7128980

SCHEMBL7128980

Cc1cccc(C(O)C(Cl)(Cl)Cl)c1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
TRPA1 O75762 2/20 0.43
GABRA1 P14867 3/20 0.42
GABRB2 P47870 3/20 0.42
HPGD P15428 3/20 0.39
CYP3A4 P08684 3/20 0.39
CYP1A2 P05177 3/20 0.39
LMNA P02545 2/20 0.39
CA2 P00918 2/20 0.39
FAAH O00519 1/20 0.39
CA1 P00915 1/20 0.39
TSHR P16473 1/20 0.39
GABRB1 P18505 1/20 0.39
GABRG2 P18507 1/20 0.39
PTGS1 P23219 1/20 0.39
SLC6A2 P23975 1/20 0.39
HTR2C P28335 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11302940 0.82 ESR1 (0.45) ALDH1A1TRPA1CYP3A4LMNATSHR
SCHEMBL11297870 0.81 TRPA1 (0.34) ALDH1A1TRPA1GABRA1GABRB2HPGD
SCHEMBL7119709 0.81 ALDH1A1 (0.48) ALDH1A1TRPA1GABRA1GABRB2HPGD
SCHEMBL7126782 0.80 LMNA (0.44) ALDH1A1TRPA1GABRA1GABRB2HPGD
SCHEMBL9193972 0.77 ALDH1A1 (0.59) ALDH1A1TRPA1GABRA1GABRB2HPGD
SCHEMBL7122079 0.77 MMP2 (0.37) ALDH1A1GABRA1GABRB2HPGDCYP3A4
SCHEMBL11785071 0.74 ALDH1A1 (0.54) ALDH1A1TRPA1GABRA1GABRB2HPGD
SCHEMBL99348 0.73 GABRA1 (0.73) ALDH1A1TRPA1GABRA1GABRB2HPGD
SCHEMBL921042 0.73 ALDH1A1 (0.59) ALDH1A1TRPA1GABRA1GABRB2HPGD
SCHEMBL30345339 0.73 GABRA1 (0.73) ALDH1A1TRPA1GABRA1GABRB2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030144541-A1 Process for preparing alpha-halogenated retones RHODIA CHIMIE (FR) 2003-07-31 US disclosed
EP-1250303-A1 METHOD FOR PREPARING ALPHA-HALOGENATED KETONES RHODIA CHIMIE (FR) 2002-10-23 EP disclosed
WO-2001055067-A1 METHOD FOR PREPARING ALPHA-HALOGENATED KETONES RHODIA CHIMIE (FR) 2001-08-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030144541-A1 Process for preparing alpha-halogenated retones ADH1A, ADH1C, RER1 ALDH1A1 15/4885TRPA1 3441/4885GABRA1 2747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.